1. AbbVie Many have scrutinized the drug industry, often for good reasons. However, medicine remains a core pillar of the broader healthcare sector, and that probably won't change anytime soon, if ever. AbbVie (ABBV 1.45%) is one of the world's prominent biopharmaceutical companies. It has a robust portfolio of drugs used to treat over 75 conditions, with core focuses in immunology, neuroscience, oncology, aesthetics, and eye care. Being a great investor doesn't have to be complicated or expensive. Often, g ...

American Express and Realty Income are both reliable blue-chip dividend stocks. Blue chip dividend stocks are usually considered stable long-term investments, but they lost their luster over the past few years as interest rates spiked. Rising rates made risk-free CDs and Treasury bills more appealing, while making it tougher for many companies to support their dividends with consistent profits. But as interest rates decline again, it might be smart to buy some of those blue chip dividend plays. So even if y ...